Batm Advanced Communicat... Share Discussion Threads

[cumnor] 19/1/2022 14:44

Have to agree, carpet, too many different strands to this company-I'm sure the sum total of all would far exceed the current SP-but ZVI seems to be unable to devise a clear strategy to capitalize on this and you wonder if he is still really up to the job.

[cumnor] 19/1/2022 14:44

Have to agree, carpet, too many different strands to this company-I'm sure the sum total of all would far exceed the current SP-but ZVI seems to be unable to devise a clear strategy to capitalize on this and you wonder if he is still really up to the job.

[fse] 19/1/2022 14:40

>steeplejack...You are correct 5G and diagnostics hardly market favourites despite the fact they will be major growth areas for quite some time to come. This has become mindless selling now somewhat reminiscent of the 2000 tech collapse.
Its not just BATM getting hit.

Thankfully they are very well funded, profitable and do not need to go to the markets or shareholders for money.

[unctuous] 19/1/2022 13:24

FSE - and, of course, omicron didn’t exist at the time of that update. Now the world is desperately short of tests and quality tests in particular. I’m expecting a bumper trading update in Feb. If I were cynical, I’d think that the company had caused this storm in a teacup to hoover up cheap shares for insiders ahead of that update. Just as well I’m not!

[picsous] 19/1/2022 13:07

Are we on our way to 40p?

[steeplejack] 19/1/2022 12:04

Diagnostics kits and 5G are not exactly the markets favourites just now but thereagain the share price movements of many a stock from Halma to Croda to Spirent are unfathomable and seem to quite ignore recent trading updates.Not really sector rotation,more a dash to cash.We can take solace from the Investors Chronicle's 170p price target which confirms there is more upside than downside :)

[boggy] 19/1/2022 11:30

Unctuous/Fse many thanks for the information you provided, I agree that none of it affects the companies value.

[car1pet] 19/1/2022 11:05

Maybe this will persuade Marom that he needs to stand down and appoint a proper CEO. I've been saying it for years

[paulisi] 19/1/2022 09:53

Price is still tumbling - short seller in the market?

[deeker] 19/1/2022 09:19

ST from investors chronicle £1bn valuation on this looking rather ridiculous now:-(

[fse] 18/1/2022 19:44

Thanks Unctuous for the link to the ruling deferral which makes it all a lot clearer, I was not aware of those details.. They actually re listed on TASE back in July 2019 so this has been a factor since then.
We received a trading update from BATM in February last year so I would expect they will address this then if not before.

A reminder from 5 months ago. Expectations for full year 2021
LEI: 213800FLQUB9J289RU66 23 August 2021
BATM Advanced Communications Limited (“BATM” or the “Group”)
Interim results for six months ended 30 June 2021
Demand for high margin diagnostic products to drive better-than-expected growth for FY 2021 – EBITDA to be significantly ahead of market expectations

[unctuous] 18/1/2022 18:22

FSE - in section 5 of the document you posted there are lots of things that BATM can tweak if inclusion in the indices is important to them. These range from the trivial (where the AGM is held) to the substantive (dropping the TASE listing!)

But I would echo your fundamental point - none of this affects the intrinsic value of the company.

[unctuous] 18/1/2022 18:17

FSE - no, that was deferred for a year. So your point about SIPP, ISAs etc stands.

[fse] 18/1/2022 17:39

Added: This is what was said last year just to add more confusion. It would suggest that there is not a problem in holding shares in an ISA as this change came into effect March 21st 2021 so if there was a problem in this respect we would have already known.
It also appears that inclusion in the indices has not been lost as there are numerous exemptions/provisions to keep it in place.

BATM Advanced Communications Ld FTSE Nationality Review
February 11 2021 - 12:38PM
UK Regulatory (RNS & others)
TIDMBVC

RNS Number : 8693O

BATM Advanced Communications Ld

11 February 2021

LEI: 213800FLQUB9J289RU66

11 February 2021

BATM Advanced Communications Limited

("BATM" or "the Group")

FTSE Nationality Review

BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, notes that in the FTSE Nationality Review of Companies published by FTSE Russell on Wednesday 3 February 2021, the Group's nationality was reassigned from the UK to Israel. This change, which is scheduled to take effect from 22 March 2021, was pursuant to rule 5.1.6 of the Ground Rules of the FTSE UK Index Series.

BATM is committed to maintaining its membership of the FTSE UK Index Series. As such, the Board of BATM, acknowledging the FTSE Russell rules in determining the nationality of an issuer, will investigate the available options for achieving this objective. BATM anticipates that this process will require 12 months. A further update will be made to the market in due course.

[fse] 18/1/2022 16:54

This might shed some light on things

[fse] 18/1/2022 16:47

This is a very confusing announcement and I assume the downside for UK holders is it references concern as to whether UK citizens can continue to hold a certain security in their Tax free savings account or not. I actually hold BATM in a Canadian tax free savings account.
There are changes in the FTSE rules due March 2022 and that would account for the 15 month timeline. Is there a new restriction we do not know about ?
The release mentions Nationality review. I guess the question is as to whether non UK companies continue to qualify for inclusion in ISA and FTSE all share tracker funds.
Telco is a US company and BATM is based out of Tel Aviv.
My understanding of index inclusion is that its a matter of market cap and Tracker funds are obligated to buy shares as they cross those markers its the same thing on TASE.

BATM said this. " it remains committed to maintaining its membership of the FTSE UK Index Series and continues to investigate the available options for achieving this objective. BATM anticipates that this process will require a further 15 months."

What confuses me is what are "available options"
Is this in reference to the LSE listing which I agree with Unctuous does not indicate any intentions to de list from UK market.
Its a matter of index inclusion.
How do they have any "options" over this they are just a set of rules.

I would also concur that "non" inclusion in the FTSE all share tracker fund would have little effect on BATM share price. It is nevertheless a problem for Tax free savings accounts should they not qualify.

Standing back from this for a moment. It all has precious little to do with the running of the company or its value.

One would have thought that the company broker Shore Capital would issue an explanatory statement. But don't hold your breath on that hope.

[unctuous] 18/1/2022 15:39

Chill. This is about index membership only. If BATM is ousted from the UK indices then the share price will not benefit from index fund buying as it passes certain benchmarks (such as entering the top 250 shares). In theory there will be some forced selling by All Share Index trackers but in practice they don’t generally fully replicate minnows such as BATM.

Listing is an entirely separate matter and there is no suggestion that the London listing is under threat.

[alter ego] 18/1/2022 13:09

had enough - sold out - no clarity, can't make any assessment.

[owenski] 18/1/2022 12:46

Avoid... until they sort this nonsense out - they've had a year, now they want another year.

Chart says this is going a lot lower.

[cumnor] 18/1/2022 12:34

Thanks, boggy. Have some Nasdaq listed shares in the SIPP but the ISA seems another matter. Lets hope Zvi isn't f......g around but need clarity on plans. That would have no bearing on the share price nor should it be price sensitive inside info-it could be a positive-so why the intrigue from him?

[boggy] 18/1/2022 12:14

I don't understand what is going on with the FTSE index issue - but agree it needs clarifying in plain English. I personally would sell my entire holding if they were to delist in the UK and move to the Nasdaq (have held for over 20 years...)as it would mean that you couldn't keep the shares in an ISA, they would have to move to a trading account or sell them before hand. If they had a dual listing on FTSE & Nasdaq this would be OK as they could still stay in ISA, but I guess it depends on how much it costs them for different listings. Not sure if this helps anyone, but I was in this situation last year with another share, so thought I would share this information.

[cumnor] 17/1/2022 19:15

Zvi needs to explain in plain English what this means. I can't understand anyway what they are doing on the UK index with so little business interest here, the contempt UK institutions and investors have for tech companies (Telco and their rather innovative medical divisions could be regarded as tech) and the more tech savvy nature of the Nasdaq which additionally has a much broader pro Israeli investor base, something the UK seems to be lacking in for reasons you can only speculate on.

[fse] 17/1/2022 17:56

Forgive my ignorance on. this one but can you be listed on LSE and not be considered part of the all share index. I thought any company would be included whether they were UK Based or not. And what in the world would take such a lengthy period to do what ?

[gbenson1] 17/1/2022 17:36

It would be interesting to know what the ground rules of the FTSE index are which were mentioned in the Feb 2021 RNS, and also what BATM are trying to achieve in this respect as they have said it may take another 15 months as they haven't achieved said aim yet!!

[fse] 17/1/2022 17:03

It has always seemed a possibility that BATM will split the two divisions and list Telco on NASDAQ as it is an American based company. Medical division is a different story.
Bit of a dilemma so they probably decided to remain on the London Market and get a listing on TASE which itself is not that old.
Would seem appropriate for them to comment on their plans in this direction for the benefit of shareholders albeit not so significant for the company itself.
Any views ?